The global Impingement Syndrome market mainly deals with products like corticosteroid injections, analgesic injections, bursa pads and capsular stretching which provide relief from shoulder pain caused due to reduced space for tendons under the acromion process or osteophytes on the undersurface of the acromion. Impingement syndrome is a common cause of shoulder pain that occurs when the rotator cuff tendons get squeezed or pinched beneath the acromion as the arm is raised. The growing geriatric population suffering from shoulder related disorders and increasing participation in sports activities resulting in shoulder injuries are factors augmenting demand for effective diagnostic and treatment solutions in the market.
Global impingement syndrome market size is estimated to value at US$ 1,380.4 million in 2023 and is expected to reach US$ 2,224 million by 2030, exhibiting a compound annual growth rate (CAGR) of 7% from 2023 to 2030.
Key Takeaways
Key players operating in the Impingement Syndrome are SABIC Innovative Plastics, Chi Mei Corporation, Teijin Limited, Mitsubishi Engineering-Plastics Corporation, Idemitsu Kosan Co., Ltd., Styron, Royal DSM, Centroplast Engineering Plastics GmbH, Asahi Kasei Chemical Corporation, and Bayer Material Science. The rising incidence of shoulder injuries is fueling demand for impingement syndrome treatments. As per estimates, shoulder impingement accounts for approximately 4.7% of all sports medicine visits in the U.S. annually.
The Impingement Syndrome Market Trends is witnessing high growth owing to rapidly growing geriatric population prone to age-related joint disorders. As per estimates, by 2050 around 16% of the global population will be aged 65 years and above. Further, lifestyle changes and increasing participation in sports and physical activities are leading to rise in cases of rotator cuff injuries and shoulder impingement globally. This is anticipated to drive demand for effective diagnostic and therapeutic solutions, especially in developed markets.
Get More Insights on- Impingement Syndrome Market
